Pune, March 03, 2020 (GLOBE NEWSWIRE) -- The global Venous Leg Ulcer Treatment Market size is projected to reach USD 4.84 billion by 2026. Recent advancements in treatment options for venous leg ulcer will have a positive impact on the growth of the market in the coming years. According to a report published by Fortune Business Insights, titled “Venous Leg Ulcer Treatment (VLU) Market Size, Share and Global Trend by Product (Compression Therapy, Advanced Wound Dressings, Others), By End User (Hospitals, Specialty Clinics, Homecare Settings, Others), and Regional Forecast, till 2026,” the market was worth USD 2.95 billion in 2018 and will exhibit a CAGR of 6.4% during the forecast period, 2019-2026.
For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/venous-leg-ulcer-vlu-treatment-market-102370
Venous leg ulcer is a serious disorder that is caused due to accidental damage to the leg. It occurs within the internal part of the leg and is consequential to the high pressure that is applied to the leg in cases of accidents. Since the healing process takes a lot of time, there is a huge emphasis on the research and development, ultimately leading to huge investment for the same. The presence of several large scale companies has opened up a huge potential for the growth of the market in the coming years. The increasing demand for faster treatment options will emerge in favour of the companies operating in the market.
High Prevalence of the Disorder Will Aid Growth of the Market
The report encompasses several factors that have contributed to the growth of the market in recent years. Among all factors, the high prevalence of venous leg ulcer has made the highest impact on the growth of the market. The increasing incidence of this disorder has encouraged companies to offer faster and efficient treatment options. The growing investment in the development of such methods will help these companies generate substantial Venous Leg Ulcer Treatment Market revenue in the coming years. According to an article published by The National Center for Biotechnology Information (NCBI) in 2010, around 600,000 people suffer from venous leg ulcer in the United States annually. The increasing incidence of this disorder will have a positive impact on the growth of the market in the coming years.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/venous-leg-ulcer-vlu-treatment-market-102370
North America Likely to Emerge Leading; Increasing Emphasis on Product R&D to Aid Growth
The report analyses ongoing Venous Leg Ulcer Treatment Market trends across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Among all regions, the market in North America is projected to emerge leading in the coming years. The increasing investment in the research and development of technologically advanced products for the treatment of the disease will have a direct impact on the growth of the regional market. Besides Europe, the market in North America will witness considerable growth in the coming years.
List of the leading companies that are currently operating in the Venous Leg Ulcer Treatment Market include:
- Integra Lifesciences
- Smith & Nephew
- Coloplast Corp.
- URGO
- 3M
- Paul Hartmann
- Bauerfeind
- Cardinal Health
- SIGVARIS GROUP
- KCI Licensing, Inc.
- Other Players
Industry Developments:
3M completed the acquisition of Acelity, Inc. and its KCI subsidiaries worldwide with an aim to expand its product offerings in advanced and surgical wound care.
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/venous-leg-ulcer-vlu-treatment-market-102370
Detailed Table of Content:
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1. Prevalence of Venous Leg Ulcer by Key Countries/Regions
4.2. The Reimbursement Scenario by Key Countries/Regions
4.3. Overview of New Product Launches and Developments
4.4. Key Industry Developments (Mergers, Acquisitions, and Partnerships)
5. Global Venous Leg Ulcer (VLU)Treatment Market Analysis, Insights and Forecast, 2015-2026
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast – By Product
5.2.1. Compression Therapy
5.2.1.1. Compression Bandages
5.2.1.2. Compression Hosiery
5.2.1.3. Others
5.2.2. Advanced Wound Dressings
5.2.3. Others
5.3. Market Analysis, Insights and Forecast – By End User
5.3.1. Hospitals
5.3.2. Specialty Clinics
5.3.3. Homecare Settings
5.3.4. Others
5.4. Market Analysis, Insights and Forecast – By Region
5.4.1. North America
5.4.2. Europe
5.4.3. Asia Pacific
5.4.4. Latin America
5.4.5. Middle East & Africa
Request for Customization: https://www.fortunebusinessinsights.com/enquiry/customization/venous-leg-ulcer-vlu-treatment-market-102370
Have a Look at Related Reports:
Wound Care Devices Market Size, Share and Industry Analysis By Product Type (Negative Pressure Wound Therapy (NPWT), Hyperbaric Oxygen Therapy (HBOT), Extracorporeal Shock Wave Therapy (ESWT)), Indication (Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds), End Users (Hospitals, Clinics, Home Care Settings) and Regional Forecast, 2018 – 2025
Active Wound Care Market Size, Share and Industry Analysis by Product Type (Biological Skin Equivalents, Growth Factors, Biological Dressings, Others), By Indication (Diabetic Foot Ulcers, Pressure Ulcers, Lower Limb Ulcers), By End User (Hospitals, Clinics, Home Care Settings), and Regional Forecast 2018-2025
Advanced Wound Care Market Size, Share and Industry Analysis, By Product (Advanced Wound Dressings, Wound Care Devices & Active Wound Care), By Indication (Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds, Others), By End User, and Regional Forecast 2018-2025
Advanced Wound Dressings Market Size, Share and Global Trend By Product Type (Alginate Dressings, Hydrogel Dressings, Film Dressings, Hydrocolloid Dressings, Antimicrobial Dressings, Foam Dressings), By Indication (Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds), By End Users (Hospitals, Clinics, Home Care Settings), and Regional Forecast 2018-2025
Negative Pressure Wound Therapy (NPWT) Market Size, Share & Industry Analysis, By Device Type (Conventional NPWT, and Single-use NPWT), By Indication (Diabetic Foot Ulcers, Pressure Ulcers, Burns & Trauma, and Others), By End User (Hospitals, Clinics, Homecare Settings, and Others) and Regional Forecast, 2019-2026
Pressure Ulcer Treatment Market Size, Share & Industry Analysis, By Ulcer Type (Stage 1, Stage 2, Stage 3, Stage 4), By Product (Wound-care Dressings, Wound-care Devices, and Others), By End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Homecare Settings), and Regional Forecast, 2019-2026
Breast Cancer Therapeutics Market Size, Share and Global Trend By Therapy (Targeted Therapy, Hormonal Therapy, Chemotherapy), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Cancer Type (Hormone Receptor, HER2+), and Geography Forecast till 2026
Lung Cancer Therapeutics Market Size, Share and Global Trend By Therapy (Targeted, Therapy, Immunotherapy, Chemotherapy), By Cancer Type (Non-small cell lung cancer (NSCLC), Small cell lung cancer (SCLC)), By Distribution Channel(Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography Forecast till 2026
Colorectal Cancer Therapeutics Market Size, Share & Industry Analysis, By Therapy (Targeted Therapy, Immunotherapy, Chemotherapy, Others), By Cancer Type (Colorectal Adenocarcinoma, Gastrointestinal Carcinoid Tumors, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026
Stomach Cancer/Gastric Cancer Treatment Market Size, Share & Industry Analysis, By Drug Type (Programmed Cell Death Protein 1 (PD-1) Inhibitors, Human Epidermal Growth Factor Receptor (HER2) Antagonists, and Others), By Disease Indication (Gastric Adenocarcinoma, Gastrointestinal Stromal Tumor (GIST)), By Route of Administration (Oral and Parenteral) By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others) and Regional Forecast, 2019-2026
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs
Press Release: https://www.fortunebusinessinsights.com/press-release/venous-leg-ulcer-vlu-treatment-market-9629